Latest news
-
GCU students success in sustainable essay writing competition12 June 2018
The University’s excellence in the field of sustainability has propelled GCU students to outstanding performances in a national competition.
-
Creating social impact in corporate America08 June 2018
Glasgow Caledonian University New York College joined a panel of industry leaders to explore how to create social impact in corporate America.
-
Gender-neutral clothing in style at Glasgow fashion exhibition06 June 2018
International Fashion Business students from GCU will style and photograph members of the public in the latest unisex designs as part of the Glasgow Science Festival.
-
GCU student journalists make a splash at awards01 June 2018
Student journalists at Glasgow Caledonian University scooped four prizes at the Scottish Student Journalism Awards 2018.
-
GCU Fashion Showcase unveils 2018 collection31 May 2018
Outstanding fashion design and creative work from the next generation of designers debuted at the 2018 GCU Fashion Showcase.
-
Dr Fiona Skillen kicks off FIFA review22 May 2018
A GCU academic has joined an expert panel to assess a qualification offered by the world football governing body FIFA.
-
Major research project into UK productivity launches22 May 2018
A major new research project aimed at increasing productivity and raising the living standards of millions of people across the UK is set to be officially launched.
-
No grey areas at Glasgow Caledonian University18 May 2018
There are no grey areas when it comes to gender-based violence. That is the message behind a new campaign launched by Glasgow Caledonian University today and backed by Alison Thewliss MP.
-
Common Good Awards celebrate inspirational students18 May 2018
The University has celebrated the achievements of its inaugural Common Good Awards winners.
-
Funding to research treatment for West’s most common cause of sight loss18 May 2018
Dr Xinhua Shu and Professor Ann Graham have been awarded £70,000 by the National Eye Research Centre to develop a new treatment for age-related macular degeneration, the most common cause of blindness in the West’s aging population.